DR NINA OBERBECK
Nina Oberbeck is Director of Preclinical Translation at Gate Bioscience, where she leads Gate’s programs and portfolio strategy. Prior to Gate, Nina worked at Maze Therapeutics in small molecule drug discovery. Nina completed her postdoctoral training at Genentech and holds a Ph.D. from the MRC Laboratory of Molecular Biology, University of Cambridge. She has published several first-author papers in high-impact journals, including Nature. In her spare time, she enjoys off-the-beaten-path travel, discovering new cultures and cuisines, and reading literary fiction.
